Core Laboratories N.V. (CLB)
NYSE: CLB · IEX Real-Time Price · USD
24.17
-0.18 (-0.74%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Core Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Net Income | 23.71 | 36.68 | 19.45 | 19.73 | -97.64 | 101.98 | Upgrade
|
| Depreciation & Amortization | 15.42 | 15.78 | 17.16 | 18.52 | 20.87 | 22.61 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -1.01 | - | -1.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.1 | - | - | - | 122.2 | - | Upgrade
|
| Stock-Based Compensation | 8.32 | 13.97 | 7.76 | 19.09 | 7.39 | 20.88 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.18 | 0.18 | -0.01 | -0.26 | 1.62 | 0.75 | Upgrade
|
| Other Operating Activities | 0.13 | -13.05 | 5.61 | 1.07 | -2.67 | -47.26 | Upgrade
|
| Change in Accounts Receivable | -9.53 | -2.62 | -10.08 | -13.52 | 46.42 | -3.19 | Upgrade
|
| Change in Inventory | 0.04 | -12.98 | -14.86 | -4.55 | 1.47 | -3.89 | Upgrade
|
| Change in Accounts Payable | -1.08 | -12.88 | 15.37 | 6.57 | -12.84 | -3.76 | Upgrade
|
| Change in Unearned Revenue | -0.04 | -1.19 | -1.82 | 2.31 | -7.92 | -5.51 | Upgrade
|
| Change in Other Net Operating Assets | 4.65 | 0.89 | -13.63 | -11.37 | -21.19 | 8.65 | Upgrade
|
| Operating Cash Flow | 41.89 | 24.79 | 24.96 | 36.58 | 57.87 | 89.53 | Upgrade
|
| Operating Cash Flow Growth | 70.07% | -0.67% | -31.78% | -36.79% | -35.36% | -19.94% | Upgrade
|
| Capital Expenditures | -12.12 | -10.58 | -10.22 | -13.54 | -11.88 | -22.27 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.93 | 0.49 | 1.89 | 0.68 | 1.73 | 0.89 | Upgrade
|
| Divestitures | - | - | 0.24 | 0.87 | - | 2.98 | Upgrade
|
| Sale (Purchase) of Intangibles | 0.23 | 0.07 | -0.03 | -0.32 | -0.5 | -0.18 | Upgrade
|
| Other Investing Activities | 2.78 | 3.38 | 4.26 | 2.08 | 18.5 | 12.91 | Upgrade
|
| Investing Cash Flow | -8.18 | -6.65 | -3.86 | -10.22 | 7.85 | -5.68 | Upgrade
|
| Long-Term Debt Issued | - | 202 | 116 | 155 | 56 | 138 | Upgrade
|
| Total Debt Issued | 113 | - | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -211 | -131 | -226 | -102 | -123 | Upgrade
|
| Total Debt Repaid | -148 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -35 | -9 | -15 | -71 | -46 | 15 | Upgrade
|
| Issuance of Common Stock | - | - | - | 60 | - | - | Upgrade
|
| Repurchase of Common Stock | -2.21 | -2.2 | -3.9 | -8.26 | -2.79 | -3.31 | Upgrade
|
| Common Dividends Paid | -1.87 | -1.87 | -1.85 | -1.83 | -12.45 | -97.57 | Upgrade
|
| Other Financing Activities | -3.14 | -5.38 | -2.62 | -1.37 | -1.77 | 0.01 | Upgrade
|
| Financing Cash Flow | -42.22 | -18.45 | -23.38 | -22.46 | -63.01 | -85.87 | Upgrade
|
| Net Cash Flow | -8.51 | -0.31 | -2.28 | 3.9 | 2.71 | -2.02 | Upgrade
|
| Free Cash Flow | 29.78 | 14.21 | 14.74 | 23.04 | 45.99 | 67.26 | Upgrade
|
| Free Cash Flow Growth | 91.77% | -3.60% | -36.02% | -49.90% | -31.62% | -25.34% | Upgrade
|
| Free Cash Flow Margin | 5.80% | 2.79% | 3.01% | 4.90% | 9.44% | 10.07% | Upgrade
|
| Free Cash Flow Per Share | 0.63 | 0.30 | 0.31 | 0.49 | 1.03 | 1.51 | Upgrade
|
| Cash Interest Paid | 11.81 | 11.2 | 9.3 | 10.48 | 11.67 | 13.63 | Upgrade
|
| Cash Income Tax Paid | 17.53 | 16.01 | 14.08 | 9.07 | 21.33 | 13.8 | Upgrade
|
| Levered Free Cash Flow | 33.27 | 20.82 | 22.42 | 24.66 | 74.58 | 80.54 | Upgrade
|
| Unlevered Free Cash Flow | 41.65 | 29.21 | 29.65 | 30.38 | 83.56 | 89.72 | Upgrade
|
| Change in Net Working Capital | 4.82 | 25.26 | 11.93 | 19.18 | -36.66 | -4.92 | Upgrade
|
Source: S&P Capital IQ. Standard template.